These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2008. Slavin MA Intern Med J; 2008 Jun; 38(6b):457-67. PubMed ID: 18588519 [TBL] [Abstract][Full Text] [Related]
3. Recommendations for the treatment of established fungal infections. Thursky KA; Playford EG; Seymour JF; Sorrell TC; Ellis DH; Guy SD; Gilroy N; Chu J; Shaw DR Intern Med J; 2008 Jun; 38(6b):496-520. PubMed ID: 18588522 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of fungal infections in hematology and oncology. Guidelines of the Working Party on Infections in Hematology and Oncology (AGIHO) of the German Society for Hematology and Oncology (DGHO)]. Böhme A; Ruhnke M; Karthaus M; Einsele H; Guth S; Heussel G; Heussel CP; Junghanss C; Kern WV; Kubin T; Sezer O; Silling G; Südhoff T; Szelényi H; Ullmann AJ; Dtsch Med Wochenschr; 2001 Dec; 126(50):1440-7. PubMed ID: 11743682 [No Abstract] [Full Text] [Related]
5. Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). ; Böhme A; Ruhnke M; Buchheidt D; Cornely OA; Einsele H; Enzensberger R; Hebart H; Heinz W; Junghanss C; Karthaus M; Krüger W; Krug U; Kubin T; Penack O; Reichert D; Reuter S; Silling G; Südhoff T; Ullmann AJ; Maschmeyer G Ann Hematol; 2009 Feb; 88(2):97-110. PubMed ID: 18853161 [TBL] [Abstract][Full Text] [Related]
6. [Pocket guide to invasive mycoses in onco-hematologic patients]. Bermúdez A; Carreras E; De la Cámara R; Eraso E; Fortún J; García-Ruiz JC; Guarro J; Jarque I; Marcos de Lucas E; Mayayo E; Pastor FJ; Pemán J; Pontón J; Quindós G; Salavert M; Sanz MA; Zaragoza R Rev Iberoam Micol; 2009; Suppl():3-199. PubMed ID: 20143497 [No Abstract] [Full Text] [Related]
7. Effectiveness of systemic antifungal prophylaxis in patients with neutropenia after chemotherapy: a meta-analysis of randomized controlled trials. Ziakas PD; Kourbeti IS; Voulgarelis M; Mylonakis E Clin Ther; 2010 Dec; 32(14):2316-36. PubMed ID: 21353103 [TBL] [Abstract][Full Text] [Related]
8. Improving efficacy of antifungal therapy by polymerase chain reaction-based strategy among febrile patients with neutropenia and cancer. Lin MT; Lu HC; Chen WL Clin Infect Dis; 2001 Nov; 33(10):1621-7. PubMed ID: 11595977 [TBL] [Abstract][Full Text] [Related]
9. New antifungal compounds and strategies for treatment of invasive fungal infections in patients with neoplastic diseases. Walsh TJ; Lyman CA Cancer Treat Res; 1995; 79():113-48. PubMed ID: 8746652 [No Abstract] [Full Text] [Related]
10. [Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology]. Kern WV; Beyer J; Böhme A; Buchheidt D; Cornely O; Einsele H; Kisro J; Krüger W; Maschmeyer G; Ruhnke M; Schmidt CA; Schwartz S; Szelenyi H; Dtsch Med Wochenschr; 2000 Dec; 125(51-52):1582-8. PubMed ID: 11199452 [No Abstract] [Full Text] [Related]
11. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature. Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575 [TBL] [Abstract][Full Text] [Related]
12. Fungal infections in cancer patients: an escalating problem. Samonis G; Bafaloukos D In Vivo; 1992; 6(2):183-93. PubMed ID: 1525339 [TBL] [Abstract][Full Text] [Related]
13. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356 [TBL] [Abstract][Full Text] [Related]
14. Between over- and undertreatment of invasive fungal disease. de Pauw BE Clin Infect Dis; 2005 Nov; 41(9):1251-3. PubMed ID: 16206098 [No Abstract] [Full Text] [Related]
15. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials. Kanda Y; Yamamoto R; Chizuka A; Hamaki T; Suguro M; Arai C; Matsuyama T; Takezako N; Miwa A; Kern W; Kami M; Akiyama H; Hirai H; Togawa A Cancer; 2000 Oct; 89(7):1611-25. PubMed ID: 11013378 [TBL] [Abstract][Full Text] [Related]
16. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases]. Karthaus M; Böhme A Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423 [TBL] [Abstract][Full Text] [Related]
17. Preventative use of antifungal drugs in patients treated for cancer. de Pauw B J Antimicrob Chemother; 2004 Feb; 53(2):130-2. PubMed ID: 14729743 [TBL] [Abstract][Full Text] [Related]
18. Empirical antifungal therapy in febrile neutropenic patients: current status. Kibbler CC Curr Top Med Mycol; 1997 Dec; 8(1-2):5-14. PubMed ID: 9504062 [TBL] [Abstract][Full Text] [Related]
19. Update on fungemia in oncology and hematology. Carreras E; Vázquez L; Rodríguez Tudela JL; Pahisa A; Azanza JR; Rovira M; de la Cámara R Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 4():42-7. PubMed ID: 21458719 [TBL] [Abstract][Full Text] [Related]
20. Fungal infections in patients with cancer. Anaissie EJ; Bodey GP Pharmacotherapy; 1990; 10(6 ( Pt 3)):164S-169S. PubMed ID: 2075117 [No Abstract] [Full Text] [Related] [Next] [New Search]